The firm believes its Orion system's combination of multiplexing, data quality, and throughput will help it carve out a space in an increasingly crowded market.
RareCyte Secures $24M to Advance Spatial Biology Platform, Expand Globally
The funding will help drive commercialization of the company's new Orion spatial biology platform and further global product expansion.
The company has developed a microscopy system that allows imaging of a full pathology slide in 21 channels with a single staining process and a rapid turnaround time.
Dec 19, 2019
RareCyte Raises $22M in Financing Round
Apr 10, 2019
Aug 29, 2017